Diversified Consumer Services
Company Overview of University of Oxford
University of Oxford is an educational institution that provides undergraduate, graduate, research, and distance learning programs. It offers courses in humanities; physical and life sciences; medical sciences; mathematics; social sciences; archaeology and anthropology; biological sciences; biochemistry; chemistry; and economics and management. The university was founded in 1096 and is based in Oxford, United Kingdom.
Oxford, OX1 2JD
Founded in 1096
Key Executives for University of Oxford
President of Kellogg College at Oxford University and Director of the Department for Continuing Education
Compensation as of Fiscal Year 2014.
University of Oxford Key Developments
Sbi Pharmaceuticals Co., Ltd. and University of Oxford Sign Agreement of the Joint Research to Start Phase II Clinical Trial to Assess the Effectiveness of 5-Aminolevulinic Acid
Jul 30 14
SBI Pharmaceuticals Co., Ltd. and University of Oxford in the United Kingdom have signed an agreement of the joint research to start a phase II clinical trial to assess the effectiveness of 5-aminolevulinic acid in preventing a reduction in cardiac output after heart bypass surgery. In heart bypass surgeries using a pump, approximately 30% of patients experience a low cardiac output state after surgery and require treatment for decreased cardiac output. SBI Pharmaceuticals will continue to pursue various potential applications of 5-ALA, and focus on research and development to provide pharmaceuticals that satisfy the unmet medical needs of as many people as possible around the world.
Bayer Health Care and University of Oxford, UK to Develop Novel Gynecological Therapies
Jul 3 14
Bayer Health Care and the University of Oxford, UK, have entered into a strategic research alliance in the area of gynecological therapies. The multi-target collaboration focuses on endometriosis and uterine fibroids with the goal of discovering and developing innovative treatment options for these diseases. Under the terms of the agreement both parties will contribute drug targets and high quality technology infrastructures. Furthermore, Bayer and the University of Oxford will share responsibilities from basic research to early clinical trials in these two diseases. Joint research projects will be performed at the University of Oxford and at the Bayer HealthCare R&D Center in Berlin, Germany. The collaboration will be for an initial period of two years but is open for extension for up to five years. Bayer is eligible to license both targets and potential drug candidates and will then be responsible for any subsequent clinical development and commercialization. The University of Oxford will receive undisclosed milestone and royalty payments depending on the successful development and approval of potential drug candidates.
University of Oxford Seeks To Sell ZPaper Mill Site
Apr 29 14
University of Oxford is now considering selling off its former paper mill land in Wolvercote, but without planning permission. The university had submitted a planning application for 190 homes to Oxford City Council. University spokesman Matt Pickles said: "The university is currently reviewing the proposed way forward in respect of the Wolvercote paper mill site. "As a result of the large number of objections submitted in response to the application, the university is considering whether or not it wishes to proceed with the application as submitted, whether it should amend it, or whether it should consider disposing of the site without resolving planning." He added that it hoped to make a decision on the potential sale next month.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries